Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Low-cytotoxic synthetic bromorutaecarpine exhibits anti-inflammation and activation of transient receptor potential vanilloid type 1 activities.

Lee CM, Gu JA, Rau TG, Yang CH, Yang WC, Huang SH, Lin FY, Lin CM, Huang ST.

Biomed Res Int. 2013;2013:795095. doi: 10.1155/2013/795095. Epub 2013 Nov 28.

2.

Synthetic Fluororutaecarpine Inhibits Inflammatory Stimuli and Activates Endothelial Transient Receptor Potential Vanilloid-Type 1.

Lee CM, Gu JA, Rau TG, Wang C, Yen CH, Huang SH, Lin FY, Lin CM, Huang ST.

Molecules. 2017 Apr 19;22(4). pii: E656. doi: 10.3390/molecules22040656.

3.

Anti-inflammatory effects and mechanisms of the ethanol extract of Evodia rutaecarpa and its bioactive components on neutrophils and microglial cells.

Ko HC, Wang YH, Liou KT, Chen CM, Chen CH, Wang WY, Chang S, Hou YC, Chen KT, Chen CF, Shen YC.

Eur J Pharmacol. 2007 Jan 26;555(2-3):211-7. Epub 2006 Oct 17.

PMID:
17109845
4.

Effects of evodiamine and rutaecarpine on the secretion of corticosterone by zona fasciculata-reticularis cells in male rats.

Yu PL, Chao HL, Wang SW, Wang PS.

J Cell Biochem. 2009 Oct 1;108(2):469-75. doi: 10.1002/jcb.22276.

PMID:
19639602
5.

Anti-inflammatory activity in skin by biomimetic of Evodia rutaecarpa extract from traditional Chinese medicine.

Yarosh DB, Galvin JW, Nay SL, Peña AV, Canning MT, Brown DA.

J Dermatol Sci. 2006 Apr;42(1):13-21. Epub 2006 Jan 19.

PMID:
16423507
6.

Partial Activation and Inhibition of TRPV1 Channels by Evodiamine and Rutaecarpine, Two Major Components of the Fruits of Evodia rutaecarpa.

Wang S, Yamamoto S, Kogure Y, Zhang W, Noguchi K, Dai Y.

J Nat Prod. 2016 May 27;79(5):1225-30. doi: 10.1021/acs.jnatprod.5b00599. Epub 2016 May 9.

PMID:
27159637
7.

Anti-inflammatory principles from the fruits of Evodia rutaecarpa and their cellular action mechanisms.

Choi YH, Shin EM, Kim YS, Cai XF, Lee JJ, Kim HP.

Arch Pharm Res. 2006 Apr;29(4):293-7.

PMID:
16681034
8.

Pharmacokinetic comparisons of rutaecarpine and evodiamine after oral administration of Wu-Chu-Yu extracts with different purities to rats.

Xu S, Peng J, Li Y, He L, Chen F, Zhang J, Ding J.

J Ethnopharmacol. 2012 Jan 31;139(2):395-400. doi: 10.1016/j.jep.2011.11.023. Epub 2011 Nov 22.

PMID:
22120018
9.

Tenuigenin exhibits anti-inflammatory activity via inhibiting MAPK and NF-κB and inducing Nrf2/HO-1 signaling in macrophages.

Lv H, Ren W, Zheng Y, Wang L, Lu G, Yi P, Ci X.

Food Funct. 2016 Jan;7(1):355-63. doi: 10.1039/c5fo00807g.

PMID:
26499342
10.

Ethanol extract from a Chinese herbal formula, "Zuojin Pill", inhibit the expression of inflammatory mediators in lipopolysaccharide-stimulated RAW 264.7 mouse macrophages.

Wang QS, Cui YL, Dong TJ, Zhang XF, Lin KM.

J Ethnopharmacol. 2012 May 7;141(1):377-85. doi: 10.1016/j.jep.2012.02.049. Epub 2012 Mar 6.

PMID:
22414473
11.
12.

3β-Angeloyloxy-8β,10β-dihydroxyeremophila-7(11)-en-12,8α-lactone Inhibits Lipopolysaccharide-Induced Nitric Oxide Production in RAW264.7 Cells.

Sun X, Jiang C, Ma L, Zhao X, Chang J, Zheng B, Li L, Xie W, Li X.

Biol Pharm Bull. 2015;38(6):836-43. doi: 10.1248/bpb.b14-00709.

13.

Transdermal behaviors comparisons among Evodia rutaecarpa extracts with different purity of evodiamine and rutaecarpine and the effect of topical formulation in vivo.

Chen F, Li S, Li D, Ding JS.

Fitoterapia. 2012 Jul;83(5):954-60. doi: 10.1016/j.fitote.2012.04.021. Epub 2012 Apr 29.

PMID:
22565145
14.

Rutaecarpine prevented dysfunction of endothelial gap junction induced by Ox-LDL via activation of TRPV1.

Peng WJ, Liu Y, Yu YR, Fu YQ, Zhao Y, Kuang HB, Huang QR, He M, Luo D.

Eur J Pharmacol. 2015 Jun 5;756:8-14. doi: 10.1016/j.ejphar.2015.02.051. Epub 2015 Mar 17.

PMID:
25794845
15.

Progress in Studies on Rutaecarpine. II.--Synthesis and Structure-Biological Activity Relationships.

Son JK, Chang HW, Jahng Y.

Molecules. 2015 Jun 11;20(6):10800-21. doi: 10.3390/molecules200610800. Review.

16.

Synthesis and vasodilator effects of rutaecarpine analogues which might be involved transient receptor potential vanilloid subfamily, member 1 (TRPV1).

Chen Z, Hu G, Li D, Chen J, Li Y, Zhou H, Xie Y.

Bioorg Med Chem. 2009 Mar 15;17(6):2351-9. doi: 10.1016/j.bmc.2009.02.015. Epub 2009 Feb 14.

PMID:
19254847
17.

Vasorelaxing action of rutaecarpine: effects of rutaecarpine on calcium channel activities in vascular endothelial and smooth muscle cells.

Wang GJ, Wu XC, Chen CF, Lin LC, Huang YT, Shan J, Pang PK.

J Pharmacol Exp Ther. 1999 Jun;289(3):1237-44.

18.

Progress in the studies on rutaecarpine.

Lee SH, Son JK, Jeong BS, Jeong TC, Chang HW, Lee ES, Jahng Y.

Molecules. 2008 Feb 6;13(2):272-300. Review.

19.
20.

Supplemental Content

Support Center